These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2361594)

  • 41. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group.
    Ophthalmology; 1991 May; 98(5 Suppl):766-85. PubMed ID: 2062512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparisons of photocoagulation treatment in exudative age-related macular degeneration with the blue-green argon, green argon and red krypton laser wavelengths.
    Atmaca LS; Ozmert E; Gündüz K
    Ophthalmologica; 1993; 207(1):46-54. PubMed ID: 7506402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Function of the diabetic retina after panretinal argon laser coagulation.
    Seiberth V; Alexandridis E; Feng W
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(6):385-90. PubMed ID: 3678848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy.
    Kaiser RS; Maguire MG; Grunwald JE; Lieb D; Jani B; Brucker AJ; Maguire AM; Ho AC; Fine SL
    Am J Ophthalmol; 2000 Feb; 129(2):178-85. PubMed ID: 10682970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of diabetic retinopathy using panretinal laser coagulation].
    Mach R
    Cas Lek Cesk; 1992 Apr; 131(7):209-12. PubMed ID: 1638608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative study of efficacy of focal photocoagulation in diabetic macular edema according to the wave length used].
    Fernandez-Vigo J; Fandino J; Fernandez MI; Salorio MS
    J Fr Ophtalmol; 1989; 12(11):785-9. PubMed ID: 2700991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of recurrent juxtafoveal subretinal neovascular membranes with krypton red laser photocoagulation.
    Olk RJ; Burgess DB
    Ophthalmology; 1985 Aug; 92(8):1035-46. PubMed ID: 2413415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial.
    Nikkhah H; Ghazi H; Razzaghi MR; Karimi S; Ramezani A; Soheilian M
    Int Ophthalmol; 2018 Feb; 38(1):313-321. PubMed ID: 28168567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Panretinal laser photocoagulation for proliferative diabetic retinopathy: the effect of laser wavelength on macular function.
    Canning C; Polkinghorne P; Ariffin A; Gregor Z
    Br J Ophthalmol; 1991 Oct; 75(10):608-10. PubMed ID: 1954210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical study on preproliferative and proliferative diabetic retinopathy].
    Zhang CF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Aug; 11(4):242-5. PubMed ID: 2532967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathologic correlation of krypton red, argon blue-green, and argon green laser photocoagulation in the human fundus.
    Smiddy WE; Fine SL; Green WR; Glaser BM
    Retina; 1984; 4(1):15-21. PubMed ID: 6539496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Personal experience in the treatment of proliferative diabetic retinopathy using an argon laser].
    Chrapek O; Rehák J
    Cesk Slov Oftalmol; 2001 Jul; 57(4):244-9. PubMed ID: 11512438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Changes in the visual field and dark adaptation following panretinal photocoagulation in diabetic retinopathy].
    Prskavec FH; Fulmek R; Klemen C; Stelzer N
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):385-7. PubMed ID: 2433497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The efficacy of additional argon laser photocoagulation for persistent, severe proliferative diabetic retinopathy.
    Vine AK
    Ophthalmology; 1985 Nov; 92(11):1532-7. PubMed ID: 4080327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Visual fields and electroretinography following extensive photocoagulation.
    Frank RN
    Arch Ophthalmol; 1975 Aug; 93(8):591-8. PubMed ID: 1171677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of conventional argon panretinal laser photocoagulation on retinal nerve fibre layer and driving visual fields in diabetic retinopathy.
    Muqit MM; Wakely L; Stanga PE; Henson DB; Ghanchi FD
    Eye (Lond); 2010 Jul; 24(7):1136-42. PubMed ID: 20019760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An electrophysiological study on panretinal photocoagulation in diabetic retinopathy.
    Franchi A; Cordella M; Scoccianti L; Neri F; Magni R
    Metab Pediatr Syst Ophthalmol (1985); 1987; 10(3):64-7. PubMed ID: 3431421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Argon green vs. krypton red laser photocoagulation for extrafoveal choroidal neovascularization secondary to age-related macular degeneration: 3-year results of a multicentre randomized trial. Canadian Ophthalmology Study Group.
    Willan AR; Cruess AF; Ballantyne M
    Can J Ophthalmol; 1996 Feb; 31(1):11-7. PubMed ID: 8925479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diode laser (810 nm) versus argon green (514 nm) modified grid photocoagulation for diffuse diabetic macular edema.
    Akduman L; Olk RJ
    Ophthalmology; 1997 Sep; 104(9):1433-41. PubMed ID: 9307638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The electroretinogram after peripheral retinal ablation in diabetic retinopathy.
    Ogden TE; Callahan F; Riekhof FT
    Am J Ophthalmol; 1976 Apr; 81(4):397-402. PubMed ID: 944536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.